Journals / Clinical and Experimental Ocular Trauma and Infection / 2020 / Cilt: 2 - Sayı: 2

Does Staphylococcus lugdunensis pose any infection risk after a cataract surgery ?

Pages
37–42
Publication Date
2020-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This should be kept in mind in endophthalmitis in vulnerable patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The purpose of this study is to present the current risk and to examine the biofilm formation ability and the antibiotic sensitivity of S. lugdunensis that were isolated from the cataract surgeries and to minimize the risks that are likely to occur due to S. lugdunensis following cataract surgeries.
📊
Key Findings & Data:The strains were identified with ID 32 Staph and VITEK II system (BioMerieux).
💡
Conclusion & Impact:This should be kept in mind in endophthalmitis in vulnerable patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:cataract · surgery · staphyloccocus

Abstract

Purpose: The purpose of this study is to present the current risk and to examine the biofilm formation ability and the antibiotic sensitivity of S. lugdunensis that were isolated from the cataract surgeries and to minimize the risks that are likely to occur due to S. lugdunensis following cataract surgeries. Material and Methods: The bacteria that had been isolated from previous cataract surgeries and stored at the Microbiology Laboratory of Eskisehir Technical University, Faculty of Science, Department of Biology were used for the study. The isolates grown on blood agars were tested with gram stain, catalase, coagulase and oxidase tests. The strains were identified with ID 32 Staph and VITEK II system (BioMerieux). The RiboPrinter® Microbial Characterization System (Dupont Qualicon) and the standard EcoRI DNA preparation kit were used for Automated EcoRIRibotyping. The isolates were assessed for biofilm production according to a modified microtiter plate method and cultivation on Congo Red Agar (CRA) plates. The antibiotic sensitivity of the isolates was tested by the disc diffusion method. Vancomycin and methicillin were assessed by microdilution method. Results: We identified 12 S. lugdunensis isolates from ocular surface of patients who underwent cataract surgery. They all produced beta hemolytic rough white colonies in the blood agar. Regarding antibiotic sensitivity results, all of the tested isolates were found to be sensitive to vancomycin and levofloxacin. Cefuroxime resistance was found in two third of the strains. While 1 isolate produced strong biofilm, 4 isolates produced a moderate biofilm, with CRA method. Six isolates did not produce any biofilm. As for microtitration method, 3 isolates produced strong biofilm, while 5 isolates did not produce any biofilm. Conclusion: Vancomycin provided a consistent coverage for S. lugdunensis and should be selected as the first line of treatment for acute endophthalmitis caused by coagulase-negative staphylococcus. In our study, two thirds of the S. lugdunensis isolates were multi drug resistant, and these isolates were resistant to cefuroxime which is used as intracameral antibiotic. This should be kept in mind in endophthalmitis in vulnerable patients.

🔖

Cite This Article

ULUSOY, M. O., KIVANÇ, M. (2020). Does Staphylococcus lugdunensis pose any infection risk after a cataract surgery ?. Clinical and Experimental Ocular Trauma and Infection, Cilt: 2 - Sayı: 2, 37–42. https://ajindex.com/articles/827399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Babu E, Oropello J. Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don’t want to ignore. Expert Rev Anti Infect Ther 2011
  2. 9(10):901-7. 2.Böcher S, Tønning B, Skov RL, Prag J. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. J Clin Microbiol 2009
  3. 47(4):946-50. 3.Nesher L, Tarrand J, Chemaly RF, Rolston KV. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center Support Care Canc 2016, 10.1007/s00520-016-3493-7 4.Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995
  4. 113(12):1479–96. 5.Yannuzzi NA, Si N, Relhan N, et al. Endophthalmitis after clear corneal cataract surgery:outcomes over two decades. Am J Ophthalmol. 2017
  5. 155–9. 6.Fisch A, Salvanet A, Prazuck T, et al. Epidemiology of infective endophthalmitis in France. Lancet 1991 338:1373–6. 7.Kattan HM, Flynn HW. Jr., Pflugfelder SC, Robertson C, and Forster RK. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991 98:227–38. 8.Miller JJ, Scott IU, Flynn HW. Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am. J. Ophthalmol. 2005 139:983–7. 9.Ng JQ, Morlet N, Pearman JW, et al. Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)’s fifth report. Ophthalmology 2005 112:1199–206. 10.Chiquet C, Pechinot A, Creuzot-Garcher C, et al. Acute Postoperative Endophthalmitis Caused by Staphylococcus lugdunensis. J. Clinical Microbiol.2007, 45 (6):1673–8. 11.Cornut PL, Thuret G, Creuzot-Garcher C, et al. Relationship between baseline clinical data and microbiologic spectrum in 100 patients with acute postcataract endophthalmitis. Retina. 2012 32(3):549–57. 12.Murad-Kejbou S, Kashani AH, Capone Jr A, Ruby A. Staphylococcus lugdunensis endophthalmitis after intravitreal injection: a case series. Retin Cases Brief Rep. 2014
  6. 8(1):41–4. 13.Pandita A, Murphy C. Microbial keratitis in Waikato,New Zealand. Clin Experiment Ophthalmol. 2011
  7. 393–7. 14.Inada N, Harada N, Nakashima M, Shoji J. Severe Stap